Golden Sky Closes Financing

Written by Customer Service on December 29, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — Golden Sky Minerals Corp. (AUEN.V) (the “Company” or “Golden Sky”) is pleased to announce that, subject to regulatory approval, it has closed their private placement financing consisting of Hard Dollar Units and Flow-Through Units, for total gross proceeds of $1,157,750. Both offerings received support from strategic accredited investors.The Company has closed on 362,500 non-flow-through Units for gross proceeds of $145,000 (the “Units”), each Unit priced at $0.40 and consisting of 1 common share of the Company and 1 common share purchase warrant (the “Unit Warrants”), each Unit Warrant being exercisable for an additional common share of the Company at $0.75 for 24 months from closing, subject to the right of the Company to accelerate the exercise period should, after...

iRhythm Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on December 29, 2020. Posted in Public Companies.

SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.iRhythm’s management is scheduled to present on Tuesday, January 12, 2021 at 2:50 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.irhythmtech.com.About iRhythm Technologies, Inc.iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that...

iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption

Written by Customer Service on December 29, 2020. Posted in Public Companies.

International Multi-Center Study to Commence January 2021University of Louisville’s Trial on IORT for Large Brain Lesion Treatments AcceleratingFirst European Patient Treated for Brain Metastasis with Xoft IORT SystemNASHUA, N.H., Dec. 29, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the appointment of Santosh Kesari, MD, PhD, a world-renowned neuro-oncologist, as Principal Investigator of its International multi-center clinical trial evaluating the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® as the sole radiation therapy to treat recurrent glioblastoma (GBM) following surgical excision of the malignancy. The study is planned to commence in January 2021 at leading academic institutions and community hospitals...

Eve & Co Announces Share Consolidation

Written by Customer Service on December 29, 2020. Posted in Public Companies.

TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) — Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that it has filed articles of amendment to consolidate the Company’s issued and outstanding common shares on the basis of one (1) new common share for every ten (10) existing common shares (the “Consolidation”).As a result of the Consolidation, the 287,867,172 common shares issued and outstanding prior to the Consolidation have been reduced to approximately 28,786,717 common shares (disregarding the treatment of any resulting fractional common shares). Each shareholder’s percentage ownership in the Company and proportional voting power remains unchanged after the Consolidation, except for minor changes and adjustments resulting from the treatment of any resulting fractional common shares.The...

Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor

Written by Customer Service on December 29, 2020. Posted in Public Companies.

Sydney, AUSTRALIA, Dec. 30, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant of patent number 10,874,713 entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States Patent & Trade Mark Office.This United States patent follows the grant of the corresponding European patent announced in November 2018. The claims of the patent protect Immutep’s intellectual property relating to combined preparations comprising its lead active immunotherapy candidate eftilagimod alpha (“efti” or “IMP321”) and a PD-1 pathway inhibitor. In this case, the PD-1 pathway inhibitor is either pembrolizumab or nivolumab.The expiry date...

WOW! Unlimited Media Announces Clarification to December 24, 2020 Press Release

Written by Customer Service on December 29, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — WOW! Unlimited Media Inc. (“WOW!” or the “Company”) (TSXV: WOW; OTCQX: WOWMF) wishes to clarify certain disclosures in its press release titled “WOW! Unlimited Media Announces Grant of Stock Options to Independent Directors,” issued on December 24, 2020 (the “December 24 Press Release”). The option exercise price of C$0.40 per common voting share was calculated based on the 10-day volume weighted average price for the period ended (and including) December 16, 2020, rather than the most recent 10-day volume weighted average price, of the Company’s common voting shares as quoted on the TSX Venture Exchange. In addition, the reference in the December 24 Press Release to the Company’s stock option plan, as approved by shareholders on December 12, 2016, should have been to...

FCA Italy Extends Sponsorship Agreement with Juventus Football Club S.p.A.

Written by Customer Service on December 29, 2020. Posted in Public Companies.

FCA Italy Extends Sponsorship Agreement with Juventus Football Club S.p.A. FCA Italy S.p.A. (“FCA Italy”), a wholly owned subsidiary of Fiat Chrysler Automobiles N.V. (NYSE: FCAU / MTA: FCA) announced today that it has agreed to extend until June 2024 its sponsorship agreement with Juventus Football Club S.p.A (“Juventus”). The agreement contemplates a yearly base sponsorship fee of €45 million subject to certain variable components depending on sporting results.The renewal confirms the positive, long lasting cooperation between FCA Italy and Juventus.London, 29 December 2020For further information:tel.: +39 (011) 00 31111Email: mediarelations@fcagroup.comwww.fcagroup.comAttachmentFCA Italy Extends Sponsorship Agreement with Juventus Football Club S.p.A.

Wabash National Releases First Sustainability Report on New Investor Website

Written by Customer Service on December 29, 2020. Posted in Public Companies.

LAFAYETTE, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) — Wabash National Corporation (NYSE: WNC) today published its first Sustainability Report on its new investor website at ir.wabashnational.com.The company’s 2019 Sustainability Report references the ongoing environmental, social and governance (ESG) initiatives that demonstrate Wabash National’s commitment to sustainability and social responsibility.“Wabash National has been internally focused on ESG topics for some time. I’m pleased our external reporting is more fully reflecting our internal efforts because we have a great story to tell,” said Brent Yeagy, president and CEO. “Every day we work with our eyes turned to fulfilling our purpose of Changing How the World Reaches You™, and we do so with a responsibility to our employees, customers and communities in mind. In addition to...

Staffing 360 Solutions Announces Closing of $2.9 million Public Offering of Common Stock and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

Written by Customer Service on December 29, 2020. Posted in Public Companies.

NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a staffing company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced the closing of its previously announced underwritten public offering of 4,816,665 shares of its common stock, including the exercise in full by the underwriter of the option to purchase an additional 628,260 shares of common stock, at a public offering price of $0.60 per share, for aggregate gross proceeds of approximately $2.9 million.The Company used 75% of the net proceeds from the offering to redeem a portion of its outstanding note due September 30, 2022, and 25% of the net proceeds from the offering to redeem a portion of its Series E Preferred Stock.H.C....

Crown Castle to Present at the Citi 2021 Global Technology, Media and Telecom West Conference

Written by Customer Service on December 29, 2020. Posted in Public Companies.

HOUSTON, Dec. 29, 2020 (GLOBE NEWSWIRE) — Crown Castle International Corp. (NYSE: CCI) (“Crown Castle”) announced today that Dan Schlanger, Crown Castle’s Chief Financial Officer, is scheduled to present on Thursday, January 7, 2021 at 12:00 p.m. Eastern Time at the Citi 2021 Global Technology, Media and Telecom West Conference. Mr. Schlanger’s presentation will be broadcast live over the Internet and is expected to last approximately 45 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle’s website at http://www.crowncastle.com, where it will also be archived for replay.ABOUT CROWN CASTLECrown Castle owns, operates and leases more than 40,000 cell towers and approximately 80,000 route miles of fiber supporting small cells and fiber solutions across every major U.S....

Day: December 29, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice